GL
BMY.RT

Governors Lane’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Governors Lane’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-420,498
Closed – – 253
2020
Q4 		$0 Sell
420,498
-197,734
-32% -$421K ﹤0.01% 167
2020
Q3 		$1.39M Buy
618,232
+110,000
+22% +$314K 0.13% 76
2020
Q2 		$1.82M Sell
508,232
-508,232
-50% -$1.83M 0.19% 53
2020
Q1 		$3.86M Buy
1,016,464
+51,000
+5% +$168K 0.54% 39
2019
Q4 		$2.91M Buy
+965,464
New +$2.51M 0.47% 32

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Governors Lane's BMY.RT Position: Q1 2021 in Review

Governors Lane sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 420,498 shares.

Governors Lane first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $3.86M in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Governors Lane reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Governors Lane sold 420,498 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Governors Lane first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Governors Lane's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $3.86M in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Governors Lane's 13F filing for Q1 2021, filed 17 May 2021.